This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2018 May;160(8):45-51.

doi: 10.1007/s15006-018-0014-2.

[Overview of treatment of localized and metastatic renal cell carcinoma (RCC)]

[Article in German]

Viktoria Stühler¹, Jens Bedke²

Affiliations

Affiliations

¹ Klinik für Urologie, Universität Tübingen, Hoppe-Seyler-Str. 3, D-72070, Tübingen, Deutschland.
² Klinik für Urologie, Universität Tübingen, Hoppe-Seyler-Str. 3, D-72070, Tübingen, Deutschland. bedke@live.com.

PMID: 29721911
DOI: 10.1007/s15006-018-0014-2

Review

[Overview of treatment of localized and metastatic renal cell carcinoma (RCC)]

[Article in German]

Viktoria Stühler et al. MMW Fortschr Med. 2018 May.

. 2018 May;160(8):45-51.

doi: 10.1007/s15006-018-0014-2.

Authors

Viktoria Stühler¹, Jens Bedke²

Affiliations

¹ Klinik für Urologie, Universität Tübingen, Hoppe-Seyler-Str. 3, D-72070, Tübingen, Deutschland.
² Klinik für Urologie, Universität Tübingen, Hoppe-Seyler-Str. 3, D-72070, Tübingen, Deutschland. bedke@live.com.

PMID: 29721911
DOI: 10.1007/s15006-018-0014-2

No abstract available

Keywords: Renal cell carcinoma; checkpoint inhibition; inhibitor; surveillance after RCC treatment; tyrosine kinase.

PubMed Disclaimer

Similar articles

Pediatric and young adult renal cell carcinoma.
Ray S, Jones R, Pritchard-Jones K, Dzhuma K, van den Heuvel-Eibrink M, Tytgat G, van der Beek J, Oades G, Murphy D. Ray S, et al. Pediatr Blood Cancer. 2020 Nov;67(11):e28675. doi: 10.1002/pbc.28675. Epub 2020 Sep 1. Pediatr Blood Cancer. 2020. PMID: 32869954 Review.
A urologic perspective on management of localized and metastatic RCC.
Jain S, Alter RS, Sawczuk I. Jain S, et al. Oncology (Williston Park). 2012 Jun;26(6):537. Oncology (Williston Park). 2012. PMID: 22870538 No abstract available.
Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with renal cell carcinoma.
García Del Muro X, Gallardo E, García Carbonero I, Laínez N, José Méndez M, Maroto P, Ochoa de Olza M, Puente J, Reynes G, Rubio J, Santander C, Suárez C, Vázquez Estévez S, Castellano D. García Del Muro X, et al. Cancer Chemother Pharmacol. 2014 Jun;73(6):1095-107. doi: 10.1007/s00280-014-2413-0. Epub 2014 Feb 16. Cancer Chemother Pharmacol. 2014. PMID: 24531612 Review.
MicroRNAs in renal cell carcinoma: implications for pathogenesis, diagnosis, prognosis and therapy.
Al-Ali BM, Ress AL, Gerger A, Pichler M. Al-Ali BM, et al. Anticancer Res. 2012 Sep;32(9):3727-32. Anticancer Res. 2012. PMID: 22993312 Review.
Rapid development of metastatic Xp11 translocation renal cell carcinoma in a girl treated for neuroblastoma.
Hedgepeth RC, Zhou M, Ross J. Hedgepeth RC, et al. J Pediatr Hematol Oncol. 2009 Aug;31(8):602-4. doi: 10.1097/MPH.0b013e3181acd981. J Pediatr Hematol Oncol. 2009. PMID: 19636262 Review.

See all similar articles

Cited by

Suppressive effects of RASAL2 on renal cell carcinoma via SOX2/ERK/p38 MAPK pathway.
Wang S, Hao X, He S, Liu C, Wang Q. Wang S, et al. Exp Ther Med. 2020 Dec;20(6):151. doi: 10.3892/etm.2020.9280. Epub 2020 Oct 6. Exp Ther Med. 2020. PMID: 33093889 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information